Amelioration of Abnormalities Associated with the Metabolic Syndrome by (Spinach) Consumption and Aerobic Exercise in Rats
Overview
Endocrinology
Affiliations
The present study evaluates the protective effects of an antioxidant-rich extract of (NAOE) in abnormalities associated with the metabolic syndrome (MetS) in rats. HPTLC of NAOE revealed the presence of 13 total antioxidants, 14 flavonoids, and 10 phenolic acids. Rats administered with fructose (20% /) in drinking water for 45 days to induce abnormalities of MetS received NAOE (200 and 400 mg/kg, po), the standard drug gemfibrozil (60 mg/kg, po), aerobic exercise (AE), and a combination of NAOE 400 mg/kg and AE (NAOEAE) daily for 45 days. All treatments significantly altered the lipid profile and attenuated the fructose-elevated levels of uric acid, C-reactive protein, homocysteine, and marker enzymes (AST, LDH, and CK-MB) in serum and malondialdehyde in the heart and restored the fructose-depleted levels of glutathione and antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase). A significant decrease in blood glucose and insulin levels decreased insulin resistance, and improved glucose tolerance was observed in the treatment animals when compared with the fructose-fed animals. The best mitigation of MetS was shown by the NAOEAE treatment indicating that regular exercise along with adequate consumption of antioxidant-rich foods such as spinach in diet can help control MetS.
Anyanwu G, Anzaku D, Bulus Y, Girgi J, Donwell C, Ihuma J J Obes. 2025; 2025:5568216.
PMID: 40026359 PMC: 11870763. DOI: 10.1155/jobe/5568216.
Flores-Estrada J, Cano-Martinez A, Vargas-Gonzalez A, Castrejon-Tellez V, Cornejo-Garrido J, Martinez-Rosas M Antioxidants (Basel). 2023; 12(11).
PMID: 38001866 PMC: 10669258. DOI: 10.3390/antiox12112013.
The current status of old traditional medicine introduced from Persia to China.
Shi J, Yang Y, Zhou X, Zhao L, Li X, Yusuf A Front Pharmacol. 2022; 13:953352.
PMID: 36188609 PMC: 9515588. DOI: 10.3389/fphar.2022.953352.
Amirinejad A, Saneei Totmaj A, Mardali F, Hekmatdoost A, Emamat H, Safa M BMC Complement Med Ther. 2021; 21(1):221.
PMID: 34479550 PMC: 8418034. DOI: 10.1186/s12906-021-03396-x.
Kapar F, Ciftci G J Diabetes Metab Disord. 2021; 19(2):907-914.
PMID: 33553015 PMC: 7843847. DOI: 10.1007/s40200-020-00578-1.